CAFFCI Media-The Official Industry Media Platform Supported by a National Cosmetics Association

We sincerely thank CAFFCI Media for their attention to and coverage of JTbiotech.

China’s First Peptide Raw Material Shortlisted for Paris in-Cosmetics Award | Jitai Biotech Enters the Global Top Tier of Innovation

(Click the link to view the article)

From April 14 to 16, 2026, in-cosmetics Global 2026, the world’s top event in the beauty raw material industry, was grandly held in Paris, France. Leading the overseas expansion, Jitai Biotech made its international debut alongside its sister brand, Active Peptide Company (USA).

At this exhibition, APderma® CollaCyclic™, one of Jitai Biotech’s innovative raw materials, was successfully shortlisted for the Innovation Zone Best Ingredient Award. Regarded as one of the most valuable and authoritative innovation awards in the global cosmetic raw material sector, it features extremely stringent criteria centered on scientific breakthroughs, application value and industry leadership, with competition at the "pyramid top" of the industry.

Notably, Jitai Biotech and Active Peptide have become the first Chinese cosmetic peptide raw material enterprise team to be shortlisted for this internationally renowned award. This historic achievement not only marks that China’s peptide raw materials have officially joined the core circle of the global innovation stage, but also signifies that Chinese enterprises possess the technical strength, product competitiveness and industrial confidence to compete with international giants in the field of high-end active raw materials, breaking the long-standing monopoly of overseas enterprises in the international high-end peptide raw material market.

01 International Accreditation:

China’s Peptide Raw Materials Reach the Global Top Tier of Innovation

As the most influential innovation showcase at in-cosmetics Global, the Innovation Zone has long been a barometer of global raw material innovation trends and a core stage for the world’s top raw material enterprises to compete. Each year, thousands of raw materials worldwide participate in the selection; being shortlisted means high recognition from the international expert jury for its scientific research value, application potential and commercial prospects, serving as an "international passport" for raw material innovation capabilities.

APderma® CollaCyclic™ stood out with its breakthrough structural design and rigorously verified remarkable efficacy, earning China’s peptide raw material industry its first "innovation ticket" to this world-class stage. This is not only an authoritative certification of the R&D and technological innovation strength of the dual-brand Jitai Biotech and Active Peptide, but also a landmark event in the internationalization of China’s active peptide industry, laying a solid foundation for Chinese peptide raw materials to go global.

During the exhibition，Ms. Janet Du, CEO of the company, delivered a keynote speech titled The Next Decade of Innovation Trends in Cosmetic Peptides: From Mood Peptides, Plant-derived Peptides to Cyclic Peptides and Dendritic Spherical Peptides. She deeply interpreted global efficacy skincare trends and the evolution of peptide technologies, systematically showcasing the profound scientific research accumulation of Jitai Biotech in two core fields: "naturally derived peptides" and "high-order structural peptides". The immediate effects of mood peptides, natural compatibility of plant-derived peptides, and structural innovation of cyclic and dendritic spherical peptides attracted strong attention from customers in Europe, North America, the Middle East and Asia Pacific, with continuous on-site negotiations and multiple preliminary cooperation intentions reached.

02 Highlight of Mood Peptide Raw Material:

Acetyl Dipeptide-91 Becomes a Focus Overseas

During in-cosmetics Global 2026, Acetyl Dipeptide-91, a strategic product of Jitai Biotech, continued to gain high-frequency attention and in-depth inquiries from overseas customers with its clear application positioning and outstanding efficacy, becoming one of the most eye-catching innovative raw materials at the booth and demonstrating strong global market potential. This raw material has completed new raw material registration and is legally applicable in the Chinese market.

The current skincare market is entering an era of "multi-problem skin", with high incidence of sensitivity, redness, barrier damage and other issues. Meanwhile, the trend of "Neuro cosmetics" is rapidly rising, and skin discomfort caused by emotional fluctuations such as stress, anxiety and staying up late has become a common pain point for global consumers. Adopting the cutting-edge "Mood Peptide" concept, Acetyl Dipeptide-91 focuses on the needs of stressed and sensitive skin management, achieving multi-dimensional synergy of soothing, stabilization and repair.

As a strategic product meticulously developed by Jitai Biotech, Acetyl Dipeptide-91 has four core advantages: quickly relieving sensitive discomforts such as redness and stinging, regulating inflammatory responses, strengthening the skin barrier and improving tolerance, as well as excellent formula compatibility to synergize with anti-aging, brightening and repair systems. In addition, it is flexible in application and can be widely used in essences, creams, masks, sprays, single-dose ampoules, post-medical aesthetic repair and other formulations, meeting brands’ multi-scenario development needs.

Driven by the dual trends of "expanding sensitive skin population" and "emotional sensitivity management", Acetyl Dipeptide-91 is expected to become a core new product for Jitai Biotech to layout the global repair track and provide key raw material support for brands to create high-end differentiated repair products.

03 Three Technical Systems Build Industry Barriers:

Empower Full-scenario Needs with Ultra-light Peptides, Plant-derived Peptides and Dendritic Spherical Peptides

The global anti-aging market continues to expand; Statista data shows the market size is projected to exceed $93.1 billion by 2027. With precise targeting, mild high efficiency and safety controllability, peptides have become one of the fastest-growing core active ingredients in the efficacy skincare sector.

With more than ten years of deep cultivation in peptide R&D and production, Jitai Biotech has built three core technical systems based on independent R&D and large-scale manufacturing capabilities. Centered on Ultra-light Peptides, Plant-derived Peptides and Dendritic Spherical Peptides, supplemented by a structure optimization technology platform, it forms a complete layout from natural mildness to high-order structural innovation, continuously strengthening its leading industry barriers.

04 Green Compliance Upgrade:

TFA Free Technology Leads New International Market Standards

Against the backdrop of stricter global cosmetics industry regulation and growing consumer demand for product safety and sustainable development, Jitai Biotech and Active Peptide have taken the lead in completing the TFA Free technology upgrade, realizing fluorine-free green manufacturing in peptide synthesis. This avoids potential risks of PFAS substances from the source, practices the concept of green and sustainable development, and leads the compliance upgrade direction of the international peptide raw material industry.

This technology upgrade does not compromise product purity and activity; instead, process optimization further improves the purity and stability of peptide raw materials. While maintaining high activity and efficacy, products fully comply with higher requirements for cosmetic raw material safety and compliance in China, the EU, the US and other international markets. At present, all core products of Jitai Biotech are produced via TFA Free technology, forming a safer, more stable and sustainable peptide raw material supply system, providing compliant and reliable raw material support for global customers and further enhancing the competitiveness of Chinese peptide raw materials in the global market.

05 First Shortlisted, Leading Breakthrough:

China’s Peptide Technology Enters the World’s Core Stage

This trip to Paris for in-cosmetics Global is an important milestone in the globalization strategy of Jitai Biotech and Active Peptide (USA), as well as a historic breakthrough in the development of China’s peptide raw material industry. It not only breaks the monopoly pattern of the international high-end peptide raw material market, but also showcases the height and future potential of China’s active peptide technology to the world with solid scientific research strength, complete technical systems and high-quality product matrix, driving Chinese peptide raw materials officially into the global top tier of innovation.

In the future, Jitai Biotech will continue to deeply cultivate the peptide raw material field, focus on strategic products such as mood peptides, ultra-light peptides, plant-derived peptides and dendritic spherical peptides, let China’s active peptides continue to shine on the world stage, and promote the high-quality international development of China’s peptide industry.